|
|
Volumn 17, Issue 4, 2007, Pages 449-452
|
|
A H3 antagonist for treating allergic rhinitis: A development candidate?
|
|
Author keywords
Allergic rhinitis; Antagonist; GW 784568X; H3; Histamine
|
|
Indexed keywords
ANTIHISTAMINIC AGENT;
FLUTICASONE FUROATE;
GSK 189254;
GSK 256066;
GW 784568X;
HISTAMINE H1 RECEPTOR;
HISTAMINE H1 RECEPTOR ANTAGONIST;
HISTAMINE H3 RECEPTOR;
HISTAMINE H3 RECEPTOR ANTAGONIST;
PHOSPHODIESTERASE IV INHIBITOR;
STEROID;
UNCLASSIFIED DRUG;
ALLERGIC RHINITIS;
AMINATION;
ARTICLE;
BLOOD ANALYSIS;
CLINICAL TRIAL;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG INDICATION;
DRUG MECHANISM;
DRUG PENETRATION;
DRUG STRUCTURE;
DRUG SYNTHESIS;
DRUG TISSUE LEVEL;
HUMAN;
MONOTHERAPY;
NONHUMAN;
PROTEIN DETERMINATION;
|
|
EID: 34147140063
PISSN: 13543776
EISSN: None
Source Type: Journal
DOI: 10.1517/13543776.17.4.449 Document Type: Article |
|
Times cited : (6)
|
|
References (7)
|
